SR
Sagar Rathi
About Sagar Rathi
Data last updated:
Sagar Rathi is a Director at Ds Protection Group Private Limited (since 2013) and Director at Renuka Lifesciences Private Limited (since 2020). The companies operate in Business Services and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹1.66 Cr; the largest is Ds Protection Group Private Limited at ₹1.58 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 May 2013 | 2013 | ₹1.58 Cr (FY 2022) | Active | |
| Director | 14 Dec 2020 | 2020 | ₹8.7 Lakh (FY 2022) | Active |
Board colleagues of Sagar Rathi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vibha | 06569701 | Ds Protection Group Private Limited | Director |
| Suresh Soni | 00907071 | Renuka Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sagar Rathi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sagar Rathi
Sagar Rathi currently holds 2 directorships: Ds Protection Group Private Limited (Director, since 10 May 2013, revenue ₹1.58 Cr (FY 2022)); Renuka Lifesciences Private Limited (Director, since 14 Dec 2020, revenue ₹8.7 Lakh (FY 2022)).
Sagar Rathi was first appointed on 10 May 2013 as Director at Ds Protection Group Private Limited. The most recent appointment on record is 14 Dec 2020 at Renuka Lifesciences Private Limited.
The 2 current companies of Sagar Rathi that report revenue have a combined latest revenue of ₹1.66 Cr: Ds Protection Group Private Limited ₹1.58 Cr (FY 2022); Renuka Lifesciences Private Limited ₹8.7 Lakh (FY 2022).
The current boards of Sagar Rathi's companies include Vibha (Ds Protection Group Private Limited), Suresh Soni (Renuka Lifesciences Private Limited).